Abstract
The management of atrial fibrillation (AF) on a longterm basis with implantable device therapy is gradually becoming a clinical reality. In this development process there has been increasingly effective use of information derived from a variety of physical, technical, basic and clinical science sources1–4. It is the purpose of this brief commentary to highlight some recent contributions from the clinical electrophysiology laboratory that are relevant to the further development of device therapy both as a stand-alone therapy and as a hybrid therapy with other pharmacological and non-pharmacological approaches. We will also briefly review the clinical experience with pilot clinical studies of device therapy to date.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Waldo AL, Plumb VJ, Henthorn RW. Observations on the mechanism of atrial flutter. In: Surawicz B, Reddy P, Prystowsky EN, editors. Tachycardias. The Hague: Martinus Nijhoff; 1984: 213–29.
Tsuji H, Fujhjiki A, Tani M et al. Quantitative relationship between atrial refractoriness and the dispersion of refractoriness in atrial vulnerability. PACE 1992; 15: 403.
Ninomyia I. Direct evidence of nonuniform distribution of vagal effects on dog atria. Circ Res 1966; 19: 576.
Krol RB, Saksena S, Prakash A, Giorgberidze I, Munsif AN, Mathew P. Prospective clinical valuation of a minimal standard programmed atrial stimulation protocol for induction of atrial fibrillation and flutter in patients with and without spontaneous atrial tachyarrhythmias. (Submitted for publication).
Saksena S, Giorgberidze I, Prakash A et al. Endocardial mapping during induced atrial fibrillation. Circulation 1996; 94 (I): I - 555 (abstract).
Giorgberidze I, Saksena S, Prakash A et al. Catheter endocardial mapping of atrial fibrillation initiation during programmed right atrial stimulation. PACE 1997; 20 (II): 1965 (abstract).
Giorgberidze I, Saksena S, Krol R, Prakash A, Munsif A, Mathew P. Catheter endocardial mapping of spontaneous termination of atrial fibrillation. PACE 1997;20(II1:1065 (abstract).
Bauernfeind RA, Swiryn SP, Strasberg B, Palileo E, Scagliotti D, Rosen KM. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients. Am Heart J 1982; 103: 941–9.
Prakash A, Mathew P, Krol RB et al. Clinical and electrophysiologic predictors of arrhythmia suppression during serial drug testing in atrial fibrillation and flutter. PACE 1996; 19 (II): 673 (abstract).
Prakash A, Saksena S, Hill M et al. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol 1997; 29: 1007–14.
Levy S, Ricard P, Lau CP et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 29: 750–5.
Jung W, Kirchoff PG, Lau CP, Tsett F, Luderitz B for the Metrix system clinical investigational group. Therapy delivery with the METRIX automatic defibrillation system: threshold stability and shock safety. J Am Coll Cardiol 1997; 29 (Suppl. A): 78A (abstract).
Giorgberidze I, Saksena S, Mongeon L et al. Effects of high frequency atrial pacing in atypical atrial flutter and atrial fibrillation. J Intervent Card Electrophysiol 1997: 111–23.
Jung W, Luderitz B. Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias. Lancet 1997; 349: 853–6.
Saksena S, Prakash A, Hill M et al. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996; 28: 687–94.
Delfaut P, Prakash A, Giorgberidze I et al. Continuous overdrive pacing prevents recurrent atrial fibrillation during single and dual site right atrial pacing. PACE 1997; 20 (II): 1074 (abstract).
Prakash A, Saksena S, Krol R, Munsif A, Delfaut P, Mathew P. Necessity for atrial defibrillation shocks during and after implantation of a dual site right atrial pacing system. PACE 1997;20(11):1 128 (abstract).
Prakash A, Delfaut P, Saksena S. Management of incessant atrial fibrillation/flutter with hybrid dual site atrial pacing therapy. Circulation 1997 ( Submitted for publication) (abstract).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Saksena, S., Delfaut, P. (1998). Management of Atrial Fibrillation by Implantable Devices: From Electrophysiological Studies to Clinical Application. In: Vardas, P.E. (eds) Cardiac Arrhythmias, Pacing & Electrophysiology. Developments in Cardiovascular Medicine, vol 201. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5254-9_37
Download citation
DOI: https://doi.org/10.1007/978-94-011-5254-9_37
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6210-7
Online ISBN: 978-94-011-5254-9
eBook Packages: Springer Book Archive